Althea Group Holdings Limited is pleased to provide its Half Year Financial Report and Appendix 4D.
Althea Group Holdings Limited is pleased to provide its Half Year Financial Report and Appendix 4D.
To read the Half Year Financial Report, please click here
To read the Appendix 4D, please click here
For further information, please contact:
Althea Group Holdings
Josh Fegan
CEO & Managing Director
1300 70 20 20 | contact@althea.com.au
Australian Investors
PAC Partners Securities
03 8633 9834 | enquiries@pacpartners.com.au
Media
Julia Maguire
Executive Director, The Capital Network
+61 419 815 386 | julia@thecapitalnetwork.com.au
About Althea Group Holdings Limited (ASX:AGH)
Althea is a patient-focused medicinal cannabis company that has all the required licenses and permits to import, cultivate, produce and supply medicinal cannabis in Australia. Through a strategic partnership with cornerstone investor Aphria, one of the largest cannabis companies listed in North America, Althea has become a leading supplier of medicinal cannabis in the Australian market.
Althea’s focus on patient care underpins its business strategy. To this end, Althea has developed a mobile application and web-based platform to educate healthcare professionals on the benefits of medicinal cannabis and assist them in navigating the regulatory landscape. Althea is progressing towards its own production facility and is in the process of expanding its product portfolio, patient numbers, and global footprint.
